Under construction – not a live service
Sign in
Taking people in CanadaNo phase

Technology-Enabled Collaborative Care for Young Adults With Type 1 Diabetes and Diabetes Distress: A Feasibility Trial

Key facts

Where
Toronto, CanadaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 29 years old?

Source: NCT06804694, who can take part

Where in Canada

  • Centre for Addiction and Mental HealthToronto, CanadaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Centre for Addiction and Mental Health
Trial code
NCT06804694
Record updated
3 February 2025
Original description
The goal of the study is to evaluate the acceptability and feasibility of a co-designed, Technology-Enabled Collaborative Care for Young Adults with Type-1 Diabetes and Diabetes Distress (TECC-T1D3) program. Through this program, the investigators aim to deliver a collaborative care intervention, featuring a health coach and a virtual care team, designed to help participants manage mental health and overall wellbeing.Read full original descriptionShow less

Technology-Enabled Collaborative Care for Young Adults With Type-1 Diabetes and Diabetes Distress (TECCT1D3): Feasibility Trial of a Co-designed Intervention

The goal of the study is to evaluate the acceptability and feasibility of a co-designed, Technology-Enabled Collaborative Care for Young Adults with Type-1 Diabetes and Diabetes Distress (TECC-T1D3) program. Through this program, the investigators aim to deliver a collaborative care intervention, featuring a health coach and a virtual care team, designed to help participants manage mental health and overall wellbeing.

Inclusion: Young adult (age 18-29 years); Resident of Ontario; Living with a self-reported diagnosis of T1D of at least 1 year; Individual is community-living (people who live independently in the community and are not residing in a setting that provide institutional care or support).

Exclusion: Unable to participate in English language; Unable to participate via telephone or web-conferencing.

ClinicalTrials.gov NCT06804694